Publication
Article
Pharmacy Times
Since the implementation of the pre-school pertussis booster vaccination in the United Kingdom, one-fifth of school children with persistent cough were found to have whooping cough, according to the results of a recent study.
The study, published online on June 24, 2014, in BMJ, estimated the prevalence and clinical severity of pertussis among school-aged children who visited their primary care provider for persistent cough from November 2010 to December 2012 after the introduction of the pertussis booster. A total of 279 children 5 to 15 years of age presenting with persistent cough were included in the study.
The results indicated that 56 children (20%) had evidence of a recent pertussis infection. Among children with whooping cough, 39 had been fully vaccinated. In addition, the risk for pertussis was more than 3 times greater in children who had received the preschool pertussis booster vaccination 7 or more years ago compared with those who had received the booster shot less than 7 years ago. Pertussis risk was similar among children who received 5 and 3 courses of the booster vaccine.
“These findings will help to inform consideration of the need for an adolescent pertussis booster vaccination in the United Kingdom,” the authors conclude.
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.